We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-16.17%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$212B
AUM Growth
-$75.2B
Cap. Flow
-$21.6B
Cap. Flow %
-10.18%
Top 10 Hldgs %
16.53%
Holding
8,948
New
748
Increased
2,253
Reduced
4,775
Closed
880

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$828M
2
AAPL icon
Apple
AAPL
+$800M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$654M
4
BA icon
Boeing
BA
+$592M
5
JPM icon
JPMorgan Chase
JPM
+$416M

Sector Composition

Rank Sector Weight
1 Technology 10.37%
2 Healthcare 6.89%
3 Financials 5.79%
4 Consumer Discretionary 5.66%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAMO icon
6101
Cambria Value and Momentum ETF
VAMO
$109M
$35K ﹤0.01%
2,145
-2,784
-56% -$53.3K
VET icon
6102
Vermilion Energy
VET
$1.73B
$35K ﹤0.01%
11,184
-7,585
-40% -$84.6K
TRAW icon
6103
Traws Pharma
TRAW
$8.24M
$35K ﹤0.01%
308
+44
+17% +$6.91K
PAMT
6104
PAMT Corp
PAMT
$281M
$35K ﹤0.01%
4,524
-6,964
-61% -$78.1K
BBSA
6105
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
$35K ﹤0.01%
668
-1,077
-62% -$55.2K
CASA
6106
DELISTED
Casa Systems, Inc. Common Stock
CASA
$35K ﹤0.01%
9,923
-25,261
-72% -$91.5K
CLVR
6107
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$35K ﹤0.01%
117
-464
-80% -$141K
UCHF
6108
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long CHF vs. USD Index due December 6, 2
UCHF
$35K ﹤0.01%
1,751
+111
+7% +$2.26K
INWK
6109
DELISTED
InnerWorkings, Inc.
INWK
$35K ﹤0.01%
30,049
-29,547
-50% -$105K
CBT icon
6110
Cabot Corp
CBT
$4.49B
$34K ﹤0.01%
1,335
-73,331
-98% -$2.79M
FLNT
6111
Fluent
FLNT
$130M
$34K ﹤0.01%
4,836
-3,961
-45% -$54.1K
GOEX icon
6112
Global X Gold Explorers ETF NEW
GOEX
$129M
$34K ﹤0.01%
1,875
+770
+70% +$18.4K
GURU icon
6113
Global X Guru Index ETF
GURU
$63.4M
$34K ﹤0.01%
1,240
-4,000
-76% -$133K
HAUZ icon
6114
Xtrackers International Real Estate ETF
HAUZ
$1.06B
$34K ﹤0.01%
1,617
+1,614
+53,800% +$43.8K
ISSC icon
6115
Innovative Solutions & Support
ISSC
$358M
$34K ﹤0.01%
10,600
-1,000
-9% -$5.1K
ITRM
6116
DELISTED
Iterum Therapeutics
ITRM
$34K ﹤0.01%
833
+703
+541% +$29.6K
PROF
6117
Profound Medical
PROF
$254M
$34K ﹤0.01%
3,545
+2,845
+406% +$36.9K
QARP icon
6118
Xtrackers Russell 1000 US Quality at a Reasonable Price ETF
QARP
$78.4M
$34K ﹤0.01%
1,447
-1,308
-47% -$36.7K
RAPT
6119
DELISTED
RAPT Therapeutics
RAPT
$34K ﹤0.01%
199
-168
-46% -$38.3K
SPXV icon
6120
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.4M
$34K ﹤0.01%
1,290
+1,146
+796% +$36.5K
TOVX icon
6121
Theriva Biologics
TOVX
$10.6M
$34K ﹤0.01%
429
+428
+42,800% +$48.7K
URBN icon
6122
Urban Outfitters
URBN
$6.8B
$34K ﹤0.01%
2,376
-5,514
-70% -$128K
SEAC
6123
DELISTED
Seachange International Inc
SEAC
$34K ﹤0.01%
448
-46
-9% -$3.52K
MYOV
6124
DELISTED
Myovant Sciences Ltd.
MYOV
$34K ﹤0.01%
4,437
-7,598
-63% -$85.2K
BKEP
6125
DELISTED
Blueknight Energy Partners L.P.
BKEP
$34K ﹤0.01%
37,631
-51,525
-58% -$53.5K

Similar funds

UBS Group's Q1 2020 Portfolio in Review

As of Q1 2020, UBS Group held 8,948 positions worth $212B, down 26% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group withdrew a net $21.6B in Q1 2020, closing 880 positions and reducing 4,775 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $196M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in VelocityShares Daily 2x VIX Short Term ETN worth $221M.

  • UBS Group's largest Q1 2020 buy was VelocityShares Daily 2x VIX Short Term ETN: 705,722 shares worth $221M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $834M increase.
  • UBS Group's biggest Q1 2020 reduction was Microsoft, cutting an estimated $828M.
  • UBS Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $196M.
  • UBS Group's ten largest holdings make up 17% of its $212B portfolio in Q1 2020.
  • UBS Group opened 748 new positions and closed 880 in Q1 2020.
  • UBS Group's portfolio value fell 26% quarter-over-quarter to $212B.

Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.